GPE

L-ALPHA-GLYCEROPHOSPHORYLETHANOLAMINE

Created:	1999-07-08
Last modified:	2024-09-27

Find Related PDB Entry
2 entries where GPE is found as a standalone ligand1 entries where GPE is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	27
Chiral Atom Count	2
Bond Count	26
Aromatic Bond Count	0

2D diagram of GPE

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	L-ALPHA-GLYCEROPHOSPHORYLETHANOLAMINE
Systematic Name (OpenEye OEToolkits)	2-aminoethyl [(2R)-2,3-dihydroxypropyl] hydrogen phosphate
Formula	C₅ H₁₄ N O₆ P
Molecular Weight	215.142
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=P(OCC(O)CO)(OCCN)O
SMILES	CACTVS	3.341	NCCO[P](O)(=O)OC[CH](O)CO
SMILES	OpenEye OEToolkits	1.5.0	C(COP(=O)(O)OCC(CO)O)N
Canonical SMILES	CACTVS	3.341	NCCO[P@@](O)(=O)OC[C@H](O)CO
Canonical SMILES	OpenEye OEToolkits	1.5.0	C(CO[P@](=O)(O)OC[C@@H](CO)O)N
InChI	InChI	1.03	InChI=1S/C5H14NO6P/c6-1-2-11-13(9,10)12-4-5(8)3-7/h5,7-8H,1-4,6H2,(H,9,10)/t5-/m1/s1
InChIKey	InChI	1.03	JZNWSCPGTDBMEW-RXMQYKEDSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB15872
Name	L-alpha-Glycerophosphorylethanolamine
Groups	experimental
Synonyms	Ethanolamine glycerophosphate anhydrous L-alpha-Glycerophosphorylethanolamine
CAS number	33049-08-0

Related Resource References

Resource Name	Reference
PubChem	70678815, 444183
ChEBI	CHEBI:143890

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.